Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602470 · ClinicalTrials.gov registry record
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
A clinical trial, sponsored by LEO Pharma.
- Completed
- Registry status
- 206
- Enrollment target
NCT02602470 is a clinical trial that has completed, run by LEO Pharma. The registered enrollment target is 206 participants.
The verdict
NCT02602470 has completed, sponsored by LEO Pharma.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
Study Summary
To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
Interventions
- DRUG Metronidazole cream
- DRUG Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)
- DRUG Azelaic Acid Cream
- DRUG Metronidazole gel
- DRUG Metronidazole Emulsion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2015-01-08 |
| Est. Completion | 2016-03-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02602470
The ClinicalTrials.gov registry entry for NCT02602470 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LEO Pharma, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Metronidazole cream is the first listed.
NCT02602470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02602470 about?
NCT02602470 is a clinical study titled "Preferences & Treatment Satisfaction Drivers in Rosacea Patients". To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
What is the current status of trial NCT02602470?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2015-01-08. Estimated completion is 2016-03-10.
What interventions are being tested in trial NCT02602470?
The interventions under investigation include: Metronidazole cream (DRUG), Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) (DRUG), Azelaic Acid Cream (DRUG), Metronidazole gel (DRUG), Metronidazole Emulsion (DRUG).
Who is sponsoring clinical trial NCT02602470?
This trial is sponsored by LEO Pharma, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.